Factors influencing change of preoperative treatment intent in a gastrointestinal cancer practice

Autor Schwarz, Roderich E
Vydáno 2007

Clinical trends and effects on quality metrics for surgical gastroesophageal cancer care

Autor Schwarz, Roderich E.
Vydáno v Transl Gastroenterol Hepatol (2018)

Collision tumor in form of primary adenocarcinoma and neuroendocrine carcinoma of the duodenum

Autor Peng, Lan, Schwarz, Roderich E.
Vydáno 2012

Profile of nintedanib in the treatment of solid tumors: the evidence to date

Autor Awasthi, Niranjan, Schwarz, Roderich E
Vydáno v Onco Targets Ther (2015)

Vascular challenges from pancreatoduodenectomy in the setting of coeliac artery stenosis

Autor Beane, Joal D, Schwarz, Roderich E
Vydáno v BMJ Case Rep (2017)

Experience with a simplified feeding jejunostomy technique for enteral nutrition following major visceral operations

Autor Minarich, Michael J., Schwarz, Roderich E.
Vydáno v Transl Gastroenterol Hepatol (2018)

Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancer

Autor Awasthi, Niranjan, Schwarz, Margaret A, Schwarz, Roderich E
Vydáno 2009

Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer

Autor Awasthi, Niranjan, Schwarz, Margaret A, Schwarz, Roderich E
Vydáno 2011

Pancreatoduodenectomy with or without Pyloric Preservation: A Clinical Outcomes Comparison

Autor Dineen, Sean P., Roland, Christina L., Schwarz, Roderich E.
Vydáno 2008

AHPBA/SSO/SSAT Sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma

Autor Dixon, Elijah, Abdalla, Eddie, Schwarz, Roderich E, Vauthey, Jean-Nicolas
Vydáno 2010

Augmentation of nab-paclitaxel chemotherapy response by mechanistically diverse antiangiogenic agents in preclinical gastric cancer models

Autor Awasthi, Niranjan, Schwarz, Margaret A., Zhang, Changhua, Schwarz, Roderich E.
Vydáno v Mol Cancer Ther (2018)

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer

Autor ZHANG, CHANG-HUA, AWASTHI, NIRANJAN, SCHWARZ, MARGARET A., SCHWARZ, RODERICH E.
Vydáno 2013

Cell Proliferation and Migration Are Modulated by Cdk-1-Phosphorylated Endothelial-Monocyte Activating Polypeptide II

Autor Schwarz, Margaret A., Thornton, Janet, Xu, Haiming, Awasthi, Niranjan, Schwarz, Roderich E.
Vydáno 2012

Evaluation of Poly-Mechanistic Antiangiogenic Combinations to Enhance Cytotoxic Therapy Response in Pancreatic Cancer

Autor Awasthi, Niranjan, Zhang, Changhua, Ruan, Winston, Schwarz, Margaret A., Schwarz, Roderich E.
Vydáno 2012

Superior Antitumor Activity of Nanoparticle Albumin-Bound Paclitaxel in Experimental Gastric Cancer

Autor Zhang, Changhua, Awasthi, Niranjan, Schwarz, Margaret A., Hinz, Stefan, Schwarz, Roderich E.
Vydáno 2013

Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II

Autor Awasthi, Niranjan, Zhang, Changhua, Hinz, Stefan, Schwarz, Margaret A, Schwarz, Roderich E
Vydáno 2013

AHPBA/SSO/SSAT sponsored consensus conference on the multidisciplinary treatment of colorectal cancer metastases

Autor Schwarz, Roderich E, Abdalla, Eddie K, Aloia, Thomas A, Vauthey, Jean-Nicolas
Vydáno 2013

Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer

Autor Awasthi, Niranjan, Monahan, Sheena, Stefaniak, Alexis, Schwarz, Margaret A., Schwarz, Roderich E.
Vydáno v Oncotarget (2017)

The N Terminus of Pro-endothelial Monocyte-activating Polypeptide II (EMAP II) Regulates Its Binding with the C Terminus, Arginyl-tRNA Synthetase, and Neurofilament Light Protein

Autor Xu, Haiming, Malinin, Nikolay L., Awasthi, Niranjan, Schwarz, Roderich E., Schwarz, Margaret A.
Vydáno v J Biol Chem (2015)

Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer

Autor Awasthi, Niranjan, Hinz, Stefan, Brekken, Rolf A., Schwarz, Margaret A., Schwarz, Roderich E.
Vydáno v Cancer Lett (2014)